13F HOLDINGS REPORT
Paradigm Biocapital Advisors LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001855655-23-000003
Total Value
$851.9M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INCYTE CORP | INCY | 852,830 | $68.5M | 8.04% |
| 2 | BIOGEN INC | BIIB | 238,772 | $66.1M | 7.76% |
| 3 | MIRATI THERAPEUTICS INC | 60468T105 | 1,267,970 | $57.5M | 6.74% |
| 4 | HORIZON THERAPEUTICS PUB L | G46188101 | 477,585 | $54.3M | 6.38% |
| 5 | LEGEND BIOTECH CORP | LEGN | 1,054,870 | $52.7M | 6.18% |
| 6 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,751,167 | $51.2M | 6.00% |
| 7 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,954,512 | $49.7M | 5.84% |
| 8 | IMMUNOCORE HLDGS PLC | IMCR | 857,925 | $49.0M | 5.75% |
| 9 | ASCENDIS PHARMA A/S | ASND | 352,808 | $43.1M | 5.06% |
| 10 | VOR BIOPHARMA INC | VOR | 6,442,825 | $42.8M | 5.03% |
| 11 | UNITED THERAPEUTICS CORP DEL | UTHR | 148,892 | $41.4M | 4.86% |
| 12 | SEAGEN INC | SE | 286,288 | $36.8M | 4.32% |
| 13 | BICYCLE THERAPEUTICS PLC | BCYC | 1,233,280 | $36.5M | 4.29% |
| 14 | ARGENX SE | ARGX | 89,556 | $33.9M | 3.98% |
| 15 | AKERO THERAPEUTICS INC | 00973Y108 | 604,544 | $33.1M | 3.89% |
| 16 | ARCELLX INC | ACLX | 882,101 | $27.3M | 3.21% |
| 17 | KARUNA THERAPEUTICS INC | 48576A100 | 106,210 | $20.9M | 2.45% |
| 18 | ARVINAS INC | ARVN | 599,599 | $20.5M | 2.41% |
| 19 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,317,634 | $17.0M | 2.00% |
| 20 | CRINETICS PHARMACEUTICALS IN | CRNX | 890,105 | $16.3M | 1.91% |
| 21 | ZAI LAB LTD | ZLAB | 515,274 | $15.8M | 1.86% |
| 22 | POSEIDA THERAPEUTICS INC | 73730P108 | 2,434,816 | $12.9M | 1.51% |
| 23 | PROTHENA CORP PLC | PRTA | 75,000 | $4.5M | 0.53% |